These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 241799)

  • 1. Effect of delta9-tetrahydrocannabinol on experimental hypertension in rats.
    Varma DR; Goldbaum D
    J Pharm Pharmacol; 1975 Oct; 27(10):790-1. PubMed ID: 241799
    [No Abstract]   [Full Text] [Related]  

  • 2. Delta9-tetrahydrocannabinol: depression of ventilatory regulation; other respiratory and cardiovascular effects.
    Moss IR; Friedman E
    Life Sci; 1976 Jul; 19(1):99-104. PubMed ID: 940439
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of tolerance to the bradycardic effect of delta 9-trans-tetrahydrocannabinol in rats.
    Kaymakçalan S; Sivil S
    Pharmacology; 1974; 12(4-5):290-5. PubMed ID: 4449891
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemodynamic and myocardial effects of (-)-delta9-trans-tetrahydrocannabinol in anesthetized dogs.
    Cavero I; Buckley JP; Jandhyala BS
    Eur J Pharmacol; 1973 Nov; 24(2):243-51. PubMed ID: 4765747
    [No Abstract]   [Full Text] [Related]  

  • 5. Tolerance of delta-9-tetrahydrocannabinol in the spontaneously hypertensive rat.
    Nahas GG; Schwartz IW; Adamec J; Manger WM
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):58-60. PubMed ID: 4683264
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of the central autonomic nervous system in the hypotension and bradycardia induced by (-)-delta 9-trans-tetrahydrocannabinol.
    Vollmer RR; Cavero I; Ertel RJ; Solomon TA; Buckley JP
    J Pharm Pharmacol; 1974 Mar; 26(3):186-92. PubMed ID: 4151077
    [No Abstract]   [Full Text] [Related]  

  • 7. delta9-tetrahydrocannabinol alters flow of blood to subcortical areas of the conscious rat brain.
    Goldman H; Dagirmanjian R; Drew WG; Murphy S
    Life Sci; 1975 Aug; 17(3):477-82. PubMed ID: 1160517
    [No Abstract]   [Full Text] [Related]  

  • 8. Interactions of delta9-tetrahydrocannabinol, adrenal steroids, and ethanol.
    List AF; Bartram SF; Nazar BL
    J Pharm Pharmacol; 1975 Aug; 27(8):606-7. PubMed ID: 239177
    [No Abstract]   [Full Text] [Related]  

  • 9. 9 -Tetrahydrocannabinol: a hypotensive effect in rats.
    Williams RB; Ng LK; Lamprecht F; Roth K; Kopin IJ
    Psychopharmacologia; 1973; 28(3):269-74. PubMed ID: 4691001
    [No Abstract]   [Full Text] [Related]  

  • 10. Phytohemagglutinin-induced lymphocyte transformation in humans receiving delta9-tetrahydrocannabinol.
    Lau RJ; Tubergen DG; Barr M; Domino EF; Benowitz N; Jones RT
    Science; 1976 May; 192(4241):805-7. PubMed ID: 1265484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol.
    Perez-Reyes M; Timmons MC; Davis KH; Wall EM
    Experientia; 1973 Nov; 29(11):1368-9. PubMed ID: 4761242
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of (-)- 9 -trans-tetrahydrocannabinol on regional blood flow in anesthetized dogs.
    Caverno I; Ertel R; Buckley JP; Jandhyala BS
    Eur J Pharmacol; 1972 Dec; 20(3):373-6. PubMed ID: 4643459
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential neurochemistry and temporal pattern in rats treated orally with delta9-tetrahydrocannabinol for periods up to six months.
    Luthra UL; Rosenkrantz H; Heyman IA; Braude MC
    Toxicol Appl Pharmacol; 1975 May; 32(2):418-31. PubMed ID: 1171540
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the bradycardia induced by (-)- -trans-tetrahydrocannabinol in anesthetized dogs.
    Cavero I; Solomon T; Buckley JP; Jandhyala BS
    Eur J Pharmacol; 1973 Jun; 22(3):263-9. PubMed ID: 4354577
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of delta9-tetrahydrocannabinol (THC) on several rodent learning paradigms.
    Robichaud RC; Hefner MA; Anderson JE; Goldberg ME
    Pharmacology; 1973; 10(1):1-11. PubMed ID: 4751537
    [No Abstract]   [Full Text] [Related]  

  • 16. delta9-Tetrahydrocannabinol and dimethylheptylpyran induced tachycardia in the conscious rat.
    Osgood PF; Howes JF
    Life Sci; 1977 Nov; 21(9):1329-36. PubMed ID: 927033
    [No Abstract]   [Full Text] [Related]  

  • 17. Delta9-tetrahydrocannabinol induced inhibition of predatory aggression in the rat.
    Kilbey MM; Moore JW
    Psychopharmacologia; 1973 Jul; 31(2):157-66. PubMed ID: 4737311
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacologic effects and physiologic disposition of delta 6a,10a dimethyl heptyl tetrahydrocannabinol (DMHP) in man.
    Lemberger L; McMahon R; Archer R; Matsumoto K; Rowe H
    Clin Pharmacol Ther; 1974 Apr; 15(4):380-6. PubMed ID: 4821441
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of delta9-tetrahydrocannabinol on active avoidance acquisition and passive avoidance retention in rats with amygdaloid lesions.
    Pandina RJ; Musty RE
    Pharmacology; 1975; 13(4):297-308. PubMed ID: 1187754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of serum prolactin in male rats by (minus)-trans-delta9-tetrahydrocannabinol.
    Daley JD; Branda LA; Rosenfeld J; Younglai EV
    J Endocrinol; 1974 Nov; 63(2):415-6. PubMed ID: 4443705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.